{"id":"https://openalex.org/W2386288792","doi":null,"title":"PEGylation of adenovirus vectors and its features","display_name":"PEGylation of adenovirus vectors and its features","alternate_titles":[],"publication_year":2006,"publication_date":"2006-01-01","ids":{"openalex":"https://openalex.org/W2386288792","mag":"2386288792"},"language":"en","primary_location":{"id":"mag:2386288792","doi":null,"is_oa":false,"landing_page_url":"https://oversea.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&filename=ZQYK200602011","pdf_url":null,"source":{"id":"https://openalex.org/S2764530780","display_name":"Chongqing Yike Daxue xuebao","issn_l":"0253-3626","issn":["0253-3626"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4323430483","host_organization_name":"Chongqing Medical University","host_organization_lineage":["https://openalex.org/P4323430483"],"host_organization_lineage_names":["Chongqing Medical University"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Chongqing Yike Daxue xuebao","raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W2386288792"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013957351","display_name":"Feng Qiu","orcid":"https://orcid.org/0000-0002-0450-229X","observed_orcids":["https://orcid.org/0000-0002-0450-229X","https://orcid.org/0000-0001-6347-7277"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Feng Qiu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5013957351"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pegylation","display_name":"PEGylation","score":0.8510000109672546},{"id":"https://openalex.org/keywords/adenovirus-vectors","display_name":"adenoviral vector","score":0.9700000286102295},{"id":"https://openalex.org/keywords/polyethylene-glycol","display_name":"polyethylene glycol","score":0.9800000190734863},{"id":"https://openalex.org/keywords/methoxy-polyethylene-glycol","display_name":"methoxy poly(ethylene glycol)","score":0.8429999947547913},{"id":"https://openalex.org/keywords/antibody-neutralization","display_name":"antibody neutralization","score":0.8840000033378601},{"id":"https://openalex.org/keywords/humoral-immune-response","display_name":"humoral immune response","score":0.9639999866485596},{"id":"https://openalex.org/keywords/plasma-half-life","display_name":"plasma half-life","score":0.8970000147819519},{"id":"https://openalex.org/keywords/gene-therapy-vectors","display_name":"gene therapy vectors","score":0.6290000081062317},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7900000214576721},{"id":"https://openalex.org/keywords/repeated-administration","display_name":"repeated administration","score":0.44200000166893005},{"id":"https://openalex.org/keywords/a549-cells","display_name":"A549 cells","score":0.8500000238418579}],"concepts":[{"id":"https://openalex.org/C2779149719","wikidata":"https://www.wikidata.org/wiki/Q682252","display_name":"PEGylation","level":3,"score":0.9383878707885742},{"id":"https://openalex.org/C202878990","wikidata":"https://www.wikidata.org/wiki/Q830465","display_name":"Capsid","level":3,"score":0.7702721357345581},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.7079805135726929},{"id":"https://openalex.org/C111599444","wikidata":"https://www.wikidata.org/wiki/Q213901","display_name":"Genetic enhancement","level":3,"score":0.6266279220581055},{"id":"https://openalex.org/C32470452","wikidata":"https://www.wikidata.org/wiki/Q2298489","display_name":"Viral vector","level":4,"score":0.6123010516166687},{"id":"https://openalex.org/C32611913","wikidata":"https://www.wikidata.org/wiki/Q2166189","display_name":"Titer","level":3,"score":0.5367146134376526},{"id":"https://openalex.org/C54400483","wikidata":"https://www.wikidata.org/wiki/Q1793202","display_name":"PEG ratio","level":2,"score":0.5310618877410889},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.5110675096511841},{"id":"https://openalex.org/C2776954459","wikidata":"https://www.wikidata.org/wiki/Q193447","display_name":"Adenoviridae","level":4,"score":0.4945060908794403},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4392911195755005},{"id":"https://openalex.org/C2779261636","wikidata":"https://www.wikidata.org/wiki/Q7003054","display_name":"Neutralizing antibody","level":3,"score":0.43691039085388184},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.4294176995754242},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4226619601249695},{"id":"https://openalex.org/C2776964284","wikidata":"https://www.wikidata.org/wiki/Q410083","display_name":"Polyethylene glycol","level":2,"score":0.3992565870285034},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.30095240473747253},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.29980704188346863},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2942569851875305},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.24913492798805237},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.14763173460960388},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2386288792","doi":null,"is_oa":false,"landing_page_url":"https://oversea.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&filename=ZQYK200602011","pdf_url":null,"source":{"id":"https://openalex.org/S2764530780","display_name":"Chongqing Yike Daxue xuebao","issn_l":"0253-3626","issn":["0253-3626"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4323430483","host_organization_name":"Chongqing Medical University","host_organization_lineage":["https://openalex.org/P4323430483"],"host_organization_lineage_names":["Chongqing Medical University"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Chongqing Yike Daxue xuebao","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1984376606","https://openalex.org/W2022668894","https://openalex.org/W1979989636","https://openalex.org/W2064074518","https://openalex.org/W2412580992","https://openalex.org/W2038526143","https://openalex.org/W2027583787","https://openalex.org/W180906971","https://openalex.org/W2054797383"],"abstract_inverted_index":{"Objective:":[0],"To":[1],"enhanced":[2],"the":[3,45,60,70,93],"physical":[4],"stability":[5],"of":[6,16,69,98,109],"adenovirus":[7,17],"vectors(Adv)":[8],"and":[9,44,106],"ablated":[10],"humoral":[11],"immune":[12],"responses":[13],"by":[14,25],"PEGylation":[15,67],"with":[18,30,103],"polyethylene":[19],"glycols.Methods:":[20],"PEGylated":[21,26,79],"Adv(PEG-Adv)":[22],"was":[23,36],"constructed":[24],"adenoviral":[27,99],"capsid":[28],"proteins":[29],"activated":[31],"methoxypolyethylene":[32],"glycols,and":[33],"gene":[34,100,111],"expression":[35],"evaluated":[37],"using":[38],"A549":[39],"cells.Furthermore,the":[40],"plasma":[41],"half":[42],"life":[43],"antibody":[46,57,62],"evasion":[47],"ability":[48,71],"were":[49],"also":[50],"evaluated.Results:":[51],"PEG-adv":[52],"could":[53,91],"be":[54],"protected":[55],"from":[56],"neutralization":[58],"in":[59,113],"high":[61],"titers":[63],"to":[64,72],"adenovirus,suggesting":[65],"that":[66],"improve":[68],"administer":[73],"Adv":[74,80],"on":[75],"a":[76],"repeated":[77],"basis.Conclusion:":[78],"can":[81],"maintain":[82],"strong":[83],"protective":[84],"activity":[85],"against":[86],"antibodies.The":[87],"approach":[88],"described":[89],"here":[90],"form":[92],"basis":[94],"for":[95],"further":[96],"development":[97],"therapy":[101],"vectors":[102],"improved":[104],"pharmacokinetics":[105],"increased":[107],"efficiency":[108],"therapeutic":[110],"transfer":[112],"disease.":[114]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2386288792","counts_by_year":[],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
